(Q34600119)

3 August 2017

Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis (English)

1 reference

3 August 2017

0 references

0 references

0 references

A Lubbad

1

1 reference

3 August 2017

M A Oriowo

series ordinal

2

1 reference

3 August 2017

I Khan

series ordinal

3

1 reference

3 August 2017

11 November 2008

1 reference

Molecular and Cellular Biochemistry

3 August 2017

1 reference

3 August 2017

322

1 reference

3 August 2017

127-135

1 reference

3 August 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-008-9949-4

3 August 2017

0 references

cites work

Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11010-008-9949-4

MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis

21 January 2018

1 reference

12 December 2020

Antibiotics for inflammatory bowel disease: do they work?

1 reference

12 December 2020

Toll-like receptor 4 regulates colitis-associated adenocarcinoma development in interleukin-10-deficient (IL-10(-/-)) mice

1 reference

12 December 2020

TLR4 signalling in the intestine in health and disease

1 reference

12 December 2020

VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.

1 reference

12 December 2020

Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword

1 reference

12 December 2020

Innate immune recognition

1 reference

12 December 2020

NF-kappaB in inflammatory bowel disease

1 reference

12 December 2020

Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.

1 reference

12 December 2020

Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

1 reference

12 December 2020

Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis

1 reference

12 December 2020

Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association

1 reference

12 December 2020

Etiology and pathogenesis of inflammatory bowel disease

1 reference

12 December 2020

Toll-like receptor signaling pathways

1 reference

12 December 2020

Therapeutic targeting of toll-like receptors in gastrointestinal inflammation

1 reference

12 December 2020

Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease

1 reference

12 December 2020

TLR4 as the mammalian endotoxin sensor

1 reference

12 December 2020

Role of gamma delta T cells in inflammatory bowel disease

1 reference

12 December 2020

Role of curcumin in health and disease

1 reference

12 December 2020

Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease

1 reference

12 December 2020

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker

1 reference

12 December 2020

Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli

1 reference

12 December 2020

Antisense inhibition of cyclooxygenase-2 causes a selective suppression of the Na+-H+ exchanger isoform 3 in rat kidney in experimental colitis

1 reference

12 December 2020

Inflammatory bowel disease: etiology and pathogenesis.

1 reference

12 December 2020

Experimental colitis is associated with ultrastructural changes in inflamed and uninflamed regions of the gastrointestinal tract

1 reference

12 December 2020

Nuclear receptors and inflammatory diseases

1 reference

12 December 2020

Role of Ca2+-sensitization in attenuated carbachol-induced contraction of the colon in a rat model of colitis

1 reference

12 December 2020

Natural products as targeted modulators of the nuclear factor-kappaB pathway

1 reference

12 December 2020

Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1ss and ERK mitogen-activated protein kinase

1 reference

12 December 2020

Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis

1 reference

12 December 2020

Toll-like receptor control of the adaptive immune responses

1 reference

12 December 2020

Inflammatory bowel disease

1 reference

12 December 2020

Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli

1 reference

12 December 2020

Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent

1 reference

12 December 2020

Current biological therapies for inflammatory bowel disease

1 reference

12 December 2020

In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide

1 reference

12 December 2020

Treatment of inflammatory bowel disease: a review of medical therapy

1 reference

12 December 2020

Hapten-induced model of chronic inflammation and ulceration in the rat colon

1 reference

12 December 2020

Curcumin therapy in inflammatory bowel disease: a pilot study

1 reference

12 December 2020

Novel therapeutic targets in the treatment of IBD

1 reference

12 December 2020

TLR2: cellular sensor for microbial and endogenous molecular patterns.

1 reference

12 December 2020

10.1007/S11010-008-9949-4

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference